Skip to main content
Clinical Trials/CTRI/2023/09/057567
CTRI/2023/09/057567
Not yet recruiting
Phase 2

A randomized controlled trial of the efficacy of inhaled salbutamol with standard therapy vs standard therapy alone for treatment of transient tachypnoea of newborn TTNB - NOT APPLICABLE

Department of pediatrics INHS ASVINI0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of pediatrics INHS ASVINI
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Department of pediatrics INHS ASVINI

Eligibility Criteria

Inclusion Criteria

  • respiratory distress in NBB born within 6 hours of their birth

Exclusion Criteria

  • Gross congenital anomaly
  • Neonates born through meconium stained liqour
  • Any birth trauma
  • Any h/o birth asphyxia ( APGAR score \< 6 at 1 min after birth)
  • Neonatal sepsis
  • Radiological finding consistent with pneumonia
  • Presence of PPHN
  • RDS of prematurity
  • Metabolic disorder like dysglycemia

Outcomes

Primary Outcomes

Not specified

Similar Trials